Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23039034 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: Lamivudine (3TC)
2 Not yet recruiting Early Infant HIV Treatment in Botswana
Conditions: HIV;   Pediatric AIDS
Interventions: Drug: Nevirapine;   Drug: Kaletra;   Drug: Lamivudine;   Drug: Zidovudine

Indicates status has not been verified in more than two years